|
|
|
Insider
Information: |
Kewalramani Reshma |
Relationship: |
Director |
City: |
Boston |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
202,113 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$57,111,356 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
202,113 |
|
|
Total
Value |
$57,111,356 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
Percentage
Gain/Loss : |
23.1%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
CEO & President, Direc... |
2024-05-24 |
121,374 |
2018-10-08 |
0 |
Premium* |
|
Ginkgo Bioworks Holdings, Inc |
DNA |
Director |
2022-09-30 |
80,739 |
2022-06-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
58 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2023-12-13 |
4 |
AS |
$397.00 |
$2,023,906 |
D/D |
(5,098) |
108,711 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2023-12-15 |
4 |
OE |
$155.57 |
$3,115,593 |
D/D |
17,135 |
125,846 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2023-12-15 |
4 |
AS |
$407.00 |
$6,973,945 |
D/D |
(17,135) |
108,711 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2024-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
41,488 |
150,199 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2024-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
20,327 |
170,526 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2024-02-09 |
4 |
D |
$422.74 |
$3,489,719 |
D/D |
(8,255) |
162,271 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2024-02-16 |
4 |
D |
$424.01 |
$3,968,310 |
D/D |
(9,359) |
152,912 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2024-02-20 |
4 |
D |
$420.58 |
$2,952,051 |
D/D |
(7,019) |
145,893 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2024-02-23 |
4 |
D |
$431.79 |
$4,052,781 |
D/D |
(9,386) |
136,507 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2024-05-20 |
4 |
AS |
$447.00 |
$6,795,294 |
D/D |
(15,202) |
121,374 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2024-05-24 |
4 |
AS |
$457.00 |
$715,205 |
D/D |
(1,565) |
121,374 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
CEO & President |
|
2024-05-24 |
4 |
OE |
$187.53 |
$293,484 |
D/D |
1,565 |
122,939 |
0 |
- |
|
DNA |
Ginkgo Bioworks Holdings,... |
Director |
|
2022-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
70,921 |
70,921 |
0 |
- |
|
DNA |
Ginkgo Bioworks Holdings,... |
Director |
|
2022-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,818 |
80,739 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
|
2018-10-08 |
4 |
AS |
$186.95 |
$430,920 |
D/D |
(2,305) |
1,909 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
|
2019-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
13,315 |
15,224 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
|
2019-02-19 |
4 |
AS |
$186.75 |
$278,163 |
D/D |
(1,488) |
13,736 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
|
2019-05-15 |
4 |
AS |
$165.41 |
$39,864 |
D/D |
(241) |
13,736 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
|
2019-10-22 |
4 |
AS |
$189.00 |
$120,582 |
D/D |
(638) |
13,098 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
|
2019-10-30 |
4 |
OE |
$155.57 |
$475,577 |
D/D |
3,057 |
16,155 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
|
2019-10-30 |
4 |
AS |
$199.00 |
$608,343 |
D/D |
(3,057) |
13,098 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
|
2019-11-08 |
4 |
AS |
$199.00 |
$101,291 |
D/D |
(509) |
13,098 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
|
2019-11-08 |
4 |
OE |
$155.57 |
$79,185 |
D/D |
509 |
13,607 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
|
2019-11-15 |
4 |
AS |
$205.95 |
$12,563 |
D/D |
(61) |
13,098 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
|
2019-11-25 |
4 |
OE |
$187.53 |
$879,891 |
D/D |
4,692 |
17,790 |
0 |
- |
|
58 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|